Tambić A, Gotovac P
Zavod za mikrobiologiju i hospitalne infekcije, Opća bolnica Sv. Duh, Zagreb.
Lijec Vjesn. 1991 Sep-Oct;113(9-10):341-3.
Since the health-care workers are frequently exposed to human blood they are considered to be at greater risk for acquiring HIV (human immunodeficiency virus). Body fluids to which universal precautions apply include blood, vaginal secretions, semen, tissues, cerebrospinal fluid, synovial, pleural, peritoneal, pericardial and amniotic fluid. These fluids of all patients are considered potentially infectious for HIV, and so are all the patients undergoing invasive procedures. Appropriate barrier precautions (gloves, aprons, masks and a protective eyewear) should prevent the skin and mucosa exposure to blood or other body fluids. If, however, a health-care worker has a parenteral of the mucosa exposure to blood or other body fluids of a HIV positive patient he should be tested for HIV antibody immediately after exposure, 6 weeks, 12 weeks and 6 months post-exposure. Among a variety of antiretroviral chemotherapeutic agents, so far, in humans only zidovudine has shown efficacy in vivo.
由于医护人员经常接触人体血液,他们被认为感染艾滋病毒(人类免疫缺陷病毒)的风险更高。普遍预防措施适用的体液包括血液、阴道分泌物、精液、组织、脑脊液、滑膜液、胸膜液、腹膜液、心包液和羊水。所有患者的这些体液都被认为可能感染艾滋病毒,所有接受侵入性操作的患者也是如此。适当的屏障预防措施(手套、围裙、口罩和防护眼镜)应可防止皮肤和黏膜接触血液或其他体液。然而,如果医护人员通过非肠道或黏膜途径接触了艾滋病毒阳性患者的血液或其他体液,他应在接触后立即、接触后6周、12周和6个月进行艾滋病毒抗体检测。在多种抗逆转录病毒化疗药物中,到目前为止,在人体中只有齐多夫定在体内显示出疗效。